Stay updated on Pembrolizumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Gastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Gastric Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision tag in the page footer updated from v3.6.5 to v3.6.6, reflecting a new page version.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdds sponsor/investigator information and links to study documents (e.g., Study Protocol and Statistical Analysis Plan), IPD sharing details and URLs, and PubMed references. It also includes MeSH terms and related indexing to better situate the trial within the scientific literature.SummaryDifference70%

- Check33 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5 on the page, indicating a minor backend update to the page metadata. No study details or eligibility information appear to be affected.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision label on the page updated from v3.6.3 to v3.6.4, indicating a minor version update. This change does not modify the study details or content shown.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, reflecting a minor update to the page version.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, signaling an update to the underlying revision rather than substantive changes to the study data or layout.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Gastric Cancer Clinical Trial page.